| abstract |
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. A method for inducing diuretic action in an animal, wherein a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite or prodrug thereof, is a second pharmaceutical composition having the ability to induce diuretic action Also disclosed is a method comprising administering in combination with. |